की कीमत क्या है Galera Therapeutics, Inc. (GRTX)

का मूल्य Galera Therapeutics, Inc. (GRTX) है $17.15

का बाजार पूंजीकरण क्या है Galera Therapeutics, Inc. (GRTX)

का बाजार पूंजीकरण Galera Therapeutics, Inc. (GRTX) है $6.51M

Galera Therapeutics, Inc. (GRTX) लाभांश प्रतिफल

Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.

वर्ष	डिविडेंड यील्ड	परिवर्तन
2026 (TTM)	0.00%	0.00%
2024	0.00%	0.00%
2023	0.00%	0.00%
2022	0.00%	0.00%
2021	0.00%	0.00%
2020	0.00%	0.00%
2019	0.00%	0.00%
2018	0.00%	0.00%
2017	0.00%	0.00%

वर्ष

डिविडेंड यील्ड

परिवर्तन

2026 (TTM)

0.00%

0.00%

2024

0.00%

0.00%

2023

0.00%

0.00%

2022

0.00%

0.00%

2021

0.00%

0.00%

2020

0.00%

0.00%

2019

0.00%

0.00%

2018

0.00%

0.00%

2017

0.00%

0.00%

कंपनी	डिविडेंड यील्ड	देश
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR
UCB S.A. UCB.BR	0.65%	BE

कंपनी

डिविडेंड यील्ड

देश